April 26, 2018


Vickery & Shepherd is currently investigating the connection between OCALIVA, its 2016 and 2018 labels, and liver injuries and death in patients. This investigation was initiated by the FDA’s recent January 2018 safety communication to healthcare providers and pharmacies based, in part, on reports of incorrect dosing in some OCALIVA patients that resulted in liver […]

Negligent Pharmaceutical Companies Beware

On January 21, 2014, the Pennsylvania Supreme Court made it clear that pharmaceutical companies who are negligent in their design or marketing of drug products will be held accountable under the law.   The drug company in Lance v. Wyeth argued that the only two bases for products liability claims were (a) impurities in the manufacturing […]

Johnson & Johnson Issues Recall of 5,000 Vials of Schizophrenia Drug

According to a Bloomberg article, Johnson & Johnson issued a recall last week of 5,000 vials of their schizophrenia drug Risperdal Consta.  The recall was issued after, “routine analysis showed one lot of the injected drug was contaminated with alternaria alternate, a common mold found in the environment.” The lot originally had 70,000 vials and […]

Chicago Judge Denies Motion For New Trial in Humira Case

August 22, 2013 – Late yesterday, Cook County Illinois Judge William J. Haddad denied Abbott Laboratories’ and Abbvie, Inc.’s motion for a new trial and to set aside the verdict in the case of Tietz v. Abbott.  This case, involving North Dakota woman Delores Tietz and the blockbuster prescription drug Humira, went to trial in May.  The […]